Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 07:39:44 +0200Tue, 25 Jun 2024 17:00:00 +0200Human medicines European public assessment report (EPAR): Zercepac, trastuzumab, Date of authorisation: 27/07/2020, Revision: 10, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/zercepacHuman medicines European public assessment report (EPAR): Zercepac, trastuzumab, Date of authorisation: 27/07/2020, Revision: 10, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/zercepacTue, 25 Jun 2024 17:00:00 +0200Human medicineZercepac : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5209_en.pdfZercepac : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5209_en.pdfTue, 11 Jul 2023 11:25:00 +0200Human medicine